Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
The study by Seaman et al provides the first confirmation of
what many have observed for years
that there is strong evidence that
appropriate treatment for drug misuse should be made available to all
prisoners, especially before release.1 It is normal
practice (and a requirement under international treaties) to provide
medical treatment for prisoners that is similar to that which they
would receive in the community. Methadone and other treatments for drug
dependence should be no different. We know that there are illicit drugs
in most prisons. Additionally, the prevalence of infection with HIV and
hepatitis B and C is higher in prisoners than in the general
population, and risk taking behaviour is widespread.
Methadone treatment was introduced into prisons in New South Wales in
1987 as a pre-release measure. Treatment has since been expanded to
become more widely available for voluntary maintenance. Despite some
initial misgivings, there has
Read all Rapid Responses